Catawba Capital Management’s Pfizer PFE Stock Holding History

Catawba Capital Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	$6.83M	Buy	198,358 +1,947	+1%	+$66.5K	1.61%	12
2018 Q1	$6.61M	Sell	196,411 -4,810	-2%	-$165K	1.59%	14
2017 Q4	$6.92M	Sell	201,221 -11,449	-5%	-$390K	1.56%	17
2017 Q3	$7.2M	Sell	212,670 -1,334	-0.6%	-$42.9K	1.63%	14
2017 Q2	$6.82M	Buy	214,004 +6,993	+3%	+$221K	1.55%	12
2017 Q1	$6.72M	Buy	207,011 +2,165	+1%	+$68.3K	1.47%	11
2016 Q4	$6.31M	Sell	204,846 -1,581	-0.8%	-$48.3K	1.48%	12
2016 Q3	$6.63M	Sell	206,427 -3,715	-2%	-$124K	1.57%	10
2016 Q2	$7.02M	Buy	210,142 +1,582	+0.8%	+$50.5K	1.7%	8
2016 Q1	$5.87M	Buy	208,560 +555	+0.3%	+$15.9K	1.49%	12
2015 Q4	$6.37M	Sell	208,005 -2,840	-1%	-$89.3K	1.73%	8
2015 Q3	$6.28M	Sell	210,845 -13,319	-6%	-$427K	1.72%	9
2015 Q2	$7.13M	Sell	224,164 -2,404	-1%	-$78.3K	1.7%	9
2015 Q1	$7.48M	Buy	226,568 +208	+0.1%	+$6.61K	1.72%	8
2014 Q4	$6.69M	Sell	226,360 -701	-0.3%	-$20.1K	1.54%	10
2014 Q3	$6.37M	Sell	227,061 -8,904	-4%	-$250K	1.48%	10
2014 Q2	$6.64M	Sell	235,965 -4,229	-2%	-$121K	1.49%	8
2014 Q1	$7.32M	Sell	240,194 -3,794	-2%	-$113K	1.75%	5
2013 Q4	$7.09M	Sell	243,988 -529	-0.2%	-$15.4K	1.7%	5
2013 Q3	$6.66M	Sell	244,517 -270	-0.1%	-$7.35K	1.75%	6
2013 Q2	$6.5M	Buy	+244,787	New	+$6.76M	1.81%	6

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Catawba Capital Management's PFE Position: Q2 2018 in Review

Catawba Capital Management increased its Pfizer (PFE) stake by 0.99% in Q2 2018, buying an estimated $66.5K and bringing the position to 198,358 shares worth $6.83M. The position accounts for 1.61% of the portfolio, ranked #12.

Catawba Capital Management first reported a position in PFE in Q2 2013 and has held it in 21 quarters since. The position peaked at $7.48M in Q1 2015. 2,204 funds tracked by Wall St. Rank hold PFE as of Q2 2018.

Catawba Capital Management held 198,358 shares of Pfizer worth $6.83M as of Q2 2018.
Catawba Capital Management bought 1,947 Pfizer shares in Q2 2018, an estimated $66.5K.
Pfizer made up 1.61% of Catawba Capital Management's portfolio in Q2 2018, its #12 holding.
Catawba Capital Management first reported a position in Pfizer in Q2 2013 and has held it in 21 quarters since.
Catawba Capital Management's Pfizer position peaked at $7.48M in Q1 2015.
2,204 funds tracked by Wall St. Rank held Pfizer as of Q2 2018.

Based on Catawba Capital Management's 13F filing for Q2 2018, filed 11 Jul 2018.